[INNOVATIVE TECHNOLOGY FOR THE TREATMENT OF COGNITIVE DISORDERS].

The authors digitized therapeutic factors used in the treatment of various forms of cognitive disorders, including dementia, with the subsequent development of a medical information system «Diagnosis and treatment of cognitive disorders». The medical information system «Diagnosis and treatment of cognitive disorders» was created on the basis of the 1C platform, supplemented by the module «Treatment of cognitive disorders», focused on supporting medical decision-making when choosing therapeutic factors for patients with cognitive disorders. It is planned to use this module in the complex activities of memory impairment classrooms.

[Lessons learnt from COVID-19: technology for organizing a forced self-isolation regime].

The lessons of COVID-19 have confirmed the effectiveness of measures aimed at strict self-isolation and quarantine. In the People's Republic of China, where any violation of the regime requirements was qualified as a criminal offense, the virus was neutralized when the pandemic was only gaining momentum in Europe and America. However, without proper organization of a restrictive regime, self-isolation can lead to negative consequences in terms of deterioration of health and standard of living.

[Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].

Aim: To compare clinical and morphological results of treatment of ischemic stroke in three groups of patients which differed by the forms and duration of an antioxidant therapy.

Material And Methods: A randomized clinical trial was performed in 8 vascular centers of the Russian Federation in 2010-2014. It included 373 patients with ischemic stroke in the carotid territory.

[Clinical and Pathophysiological Correlations in Acute Stroke, CT Visualized at Different Times].

Two hundred twenty one patients aged 32-93 years with brain infarction, admitted to a Vascular Neurology Center in the first 3-48 hours (mean 6 hours) after the onset of the symptoms of stroke with computed tomography (CT) verified diagnosis were enrolled in the study. According to the timing of the CT-verification the patients were divided into 2 groups: "early" visualization (EV 50.2%) and "late" visualization (LV, 49.

[Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction].

The paper reviews the preliminary results of a multicenter randomized clinical research. The aim of the study was to determine the optimal duration of different types of energy-correction therapy. 99 case report forms of patients with cerebral infarction were reviewed with their prior envelope randomization into three groups.